Clinical Edge Journal Scan

PsA tied with higher prevalence of coronary calcification


 

Key clinical point: In a cohort of at-risk patients with symptoms suggestive of coronary artery disease (CAD), the prevalence of coronary artery calcification (CAC) was higher in patients with psoriatic arthritis (PsA) compared with those without psoriasis or PsA.

Major finding: The prevalence of CAC score greater than 0 was significantly higher in patients with PsA vs. those without psoriasis or PsA (adjusted odds ratio, 1.28; 95% confidence interval, 1.00-1.64).

Study details: This was a cross-sectional study of 46,022 patient’s at-risk patients with symptoms suggestive of CAD from the Danish national computed tomography angiography registry, among which 1,356 had psoriasis, 370 had PsA whereas, 44,296 patients formed the reference nonpsoriasis/PsA cohort.

Disclosures: The study did not report any source of funding. No conflicts of interest were reported.

Source: Tinggaard AB et al. J Intern Med. 2021 May 12. doi: 10.1111/joim.13311 .

Recommended Reading

Trial: Fecal transplantation safe but ineffective in PsA
MDedge Rheumatology
Lower SARS-CoV-2 vaccine responses seen in patients with immune-mediated inflammatory diseases
MDedge Rheumatology
Clinical Edge Journal Scan Commentary: PsA June 2021
MDedge Rheumatology
Is fecal microbiota transplantation beneficial in active peripheral PsA?
MDedge Rheumatology
PsA: Guselkumab well tolerated with no new safety signals
MDedge Rheumatology
Secukinumab, a comprehensive biologic treatment for management of concomitant PsA and psoriasis
MDedge Rheumatology
PsA: No substantial change in body composition with ustekinumab treatment
MDedge Rheumatology
PsA: Upadacitinib shows consistent efficacy and safety in patients with inadequate response to biologics
MDedge Rheumatology
PsA: Swapping biologics gives no remarkable advantage over cycling
MDedge Rheumatology
PsA: Rates of hospitalized serious infections lower with ustekinumab vs. other biologics
MDedge Rheumatology